Healthcare IT

The TrumpRx cash-pay drug purchasing portal has officially launched, marking the rollout of a government-run website that directs patients to cash-pay channels for purchasing prescription...

GE HealthCare today announced a collaboration with Diagnoly to advance AI-enabled fetal ultrasound by integrating Diagnoly’s Fetoly solution into GE HealthCare’s Voluson women’s health ultrasound...

As global health authorities tighten their scrutiny on supply chain transparency and data reliability, pharmaceutical manufacturers must pivot toward more agile and risk-based governance models to maintain compliance and market access.

Connecting disparate compliance, risk, and operational functions into a single, cohesive framework is essential for improving institutional resilience and ensuring a consistent standard of care in modern medical environments.

The strategic application of performance indicators allows healthcare leaders to move beyond intuitive management, leveraging objective data to enhance patient outcomes and operational sustainability across complex medical institutions.

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.